Today stem cell scientists and patient advocates are descending on Toronto for the annual meeting of the International Society for Stem Cell Research. Among those registering and preparing for three days of science is Don Reed, who is one of 20 patient advocates who received a CIRM stipend to attend.
On his blog today, Reed writes about his trip to Toronto and the important role of patient advocates in promoting science:
CIRM board member Jeff Sheehy recently spoke as part of a KQED Forum radio show about the 30th anniversary of HIV/AIDS. As a long-time AIDS activist, Sheehy has been part of the fight for a cure. In his introduction, Sheehy talked about limitations of the current drug regimen for HIV/AIDS:
At the 18th Conference on Retroviruses and Opportunistic Infections (CROI) in Boston, two members of CIRM's HIV/AIDS Disease Team led by John Zaia at City of Hope presented new research showing the team's progress toward the clinic.
Duane Roth, my colleague on the CIRM governing board where he serves as one of the vice-chairs, has just published an article, with the title, "The Third Seat at the Table: An Insider's Perspective on Patient Representatives," in the Hasting's Center Report. The Center, an independent, nonpartisan, and nonprofit bioethics research institute, publishes its report six times a year to "explore the ethical, legal, and social issues in medicine, health care, public health, and the life sciences."